Lupron Depot-ped Kit
Product Images NDC 0074-2108

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Lupron Depot-ped (NDC 0074-2108). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lupron Depot Ped Spl 01

An illustration diagram of a prefilled syringe labeled with components of the Lupron Depot-PED leuprolide acetate kit. Parts identified include the plunger, finger grip, end stopper, diluent, middle stoppers, leuprolide acetate microsphere powder, barrel with a blue line, front stopper, needle and cap, and the LuproLoc safety device.*

FDA Label Image

Lupron Depot Ped Spl 02

An instructional illustration showing two hands preparing a syringe by attaching or securing a component with a twisting motion, likely demonstrating a step in the use or assembly of a Lupron Depot-PED kit syringe.*

FDA Label Image

Lupron Depot Ped Spl 03

An instructional illustration showing a hand holding a syringe with an arrow indicating upward movement of the plunger, and a label pointing to a 'blue line' on the syringe barrel. This diagram appears related to the administration or preparation of Lupron Depot-PED (leuprolide acetate) kit.*

FDA Label Image

Lupron Depot Ped Spl 04

An instructional black-and-white line drawing showing a hand holding a syringe. The illustration includes arrows pointing left and right, indicating a back-and-forth motion for preparing or mixing the syringe contents. No product text or labels are visible in the image.*

FDA Label Image

Lupron Depot Ped Spl 05

An instructional diagram showing four potential injection sites on the human body, including the upper arm, buttock, thigh, and abdomen. It also demonstrates the technique of holding a syringe at a 90-degree angle for injection.*

FDA Label Image

Lupron Depot Ped Spl 06

An instructional diagram showing a close-up view of a device or mechanism with a lever and protruding part, highlighted by a bold arrow pointing to a specific area, likely indicating an operational step or component detail for Lupron Depot-PED kit use.*

FDA Label Image

Lupron Depot Ped Spl 07

An instructional line drawing showing a hand holding a device, with an upward arrow above and a black arrow pointing down on the device, indicating a step in the use or activation of the device.*

FDA Label Image

Lupron Depot Ped Spl 08

Chemical structure diagram of leuprolide acetate, the active ingredient in Lupron Depot-PED. The diagram depicts the molecular configuration with amino acid residues and functional groups characteristic of this peptide compound.*

FDA Label Image

Lupron Depot Ped Spl 09

A line graph showing mean plus SE stimulated LH (mIU/mL) over 24 study weeks. It compares two groups: 11.25 mg naive and 11.25 mg previously treated, with a reference line at 4 mIU/mL. Both groups show a sharp decline from baseline to week 4 and then remain near or below the reference line through week 24.*

FDA Label Image

Lupron Depot Ped Spl 0a

A line chart displaying mean plus standard error (SE) stimulated luteinizing hormone (LH) levels in mIU/mL over a 24-week study period. The graph compares two groups: 30 mg naive and 30 mg previously treated, showing LH levels dropping sharply by week 4 and remaining low through week 24. A 4 mIU/mL reference line is also present.*

FDA Label Image

Lupron Depot Ped Spl 0b

Lupron Depot-PED (leuprolide acetate) Kit 11.25 mg for 1-month administration, shown on a product label. The label specifies single dose administration with the provided dual-chamber syringe, for intramuscular injection. Manufactured by AbbVie Inc., the label includes dosage details, lot and expiration information, as well as handling instructions and storage conditions.*

FDA Label Image

Lupron Depot Ped Spl 0c

Lupron Depot-PED 11.25 mg for 3-month administration kit for pediatric use. The label indicates it contains leuprolide acetate in a depot suspension form for intramuscular injection. It includes instructions emphasizing pediatric administration, a dual-chamber syringe, and storage information. The product is labeled by AbbVie Inc.*

FDA Label Image

Lupron Depot Ped Spl 0d

Drug facts panel for Lupron Depot-PED (leuprolide acetate) 30 mg for 3-month administration pediatric kit. The panel includes dosage instructions, administration warnings, product NDC code, company information (AbbVie Inc.), and a patient notice to dispense the accompanying Medication Guide. It specifies intramuscular injection and pediatric use only.*

FDA Label Image

Lupron Depot Ped Spl 0e

Lupron Depot-PED 7.5 mg kit label by AbbVie Inc. for pediatric use only, intended for 1-month intramuscular injection administration. The label includes instructions to dispense an accompanying Medication Guide, details of the kit components including a prefilled dual-chamber syringe, and safety information. Manufacturer and storage information are also provided.*

FDA Label Image

Lupron Depot Ped Spl 0f

Lupron Depot-PED kit label for pediatric use only, containing leuprolide acetate 15 mg for 1-month intramuscular injection. The label details kit components including syringes and needles, dosing instructions, and safety warnings. It is labeled by AbbVie Inc. and includes a QR code, lot number, and expiration date fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.